Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 2.970
+0.170 (6.07%)
At close: Mar 9, 2026
Indies Pharma Jamaica Balance Sheet
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 421.7 | 221.97 | 256.68 | 234.63 | 187.74 | Upgrade
|
| Cash & Short-Term Investments | 421.7 | 221.97 | 256.68 | 234.63 | 187.74 | Upgrade
|
| Cash Growth | 89.98% | -13.52% | 9.40% | 24.98% | -40.14% | Upgrade
|
| Accounts Receivable | 135.52 | 168.1 | 156.69 | 106.83 | 118.53 | Upgrade
|
| Other Receivables | 6.48 | 28.57 | 2.96 | 3.46 | 7.42 | Upgrade
|
| Receivables | 142 | 196.67 | 159.65 | 110.29 | 125.94 | Upgrade
|
| Inventory | 156.12 | 248.58 | 170.38 | 175.51 | 222.6 | Upgrade
|
| Prepaid Expenses | 135.11 | 65.04 | 110.65 | 57.61 | 36.31 | Upgrade
|
| Other Current Assets | 109.7 | 59.74 | 26.33 | 41.02 | 0.76 | Upgrade
|
| Total Current Assets | 964.62 | 792 | 723.7 | 619.06 | 573.35 | Upgrade
|
| Property, Plant & Equipment | 1,335 | 915.81 | 968.36 | 949.4 | 979.87 | Upgrade
|
| Long-Term Investments | 17.22 | 16.36 | 16.3 | 79.44 | 146.75 | Upgrade
|
| Other Intangible Assets | 494.69 | 461.71 | 441.75 | 379.31 | 317.63 | Upgrade
|
| Long-Term Deferred Tax Assets | 5.55 | 2.2 | 2.2 | - | - | Upgrade
|
| Other Long-Term Assets | 238.26 | 119.12 | 87.87 | 21.01 | 18.94 | Upgrade
|
| Total Assets | 3,055 | 2,307 | 2,240 | 2,048 | 2,037 | Upgrade
|
| Accounts Payable | 117.14 | 41.64 | 35.64 | 16.31 | 34.87 | Upgrade
|
| Short-Term Debt | 8.09 | 6.64 | 11.99 | 7.86 | 3.44 | Upgrade
|
| Current Portion of Long-Term Debt | - | 805 | - | - | - | Upgrade
|
| Current Portion of Leases | 6.42 | 43.35 | 34.19 | 1.22 | 46.58 | Upgrade
|
| Current Income Taxes Payable | 2.43 | 24.18 | 15.74 | - | - | Upgrade
|
| Other Current Liabilities | 59.67 | 13.27 | 45.27 | 35.08 | 13.32 | Upgrade
|
| Total Current Liabilities | 193.75 | 934.08 | 142.84 | 60.48 | 98.2 | Upgrade
|
| Long-Term Debt | 1,000 | - | 805 | 805 | 805 | Upgrade
|
| Long-Term Leases | - | - | 50.92 | 1.25 | - | Upgrade
|
| Other Long-Term Liabilities | 131.39 | 79.47 | 22.39 | 24.54 | 46.6 | Upgrade
|
| Total Liabilities | 1,325 | 1,014 | 1,021 | 891.27 | 949.8 | Upgrade
|
| Common Stock | 244.58 | 244.58 | 244.58 | 244.58 | 244.58 | Upgrade
|
| Retained Earnings | 591.97 | 590.58 | 515.98 | 453.9 | 383.69 | Upgrade
|
| Comprehensive Income & Other | 893.48 | 458.48 | 458.48 | 458.48 | 458.48 | Upgrade
|
| Shareholders' Equity | 1,730 | 1,294 | 1,219 | 1,157 | 1,087 | Upgrade
|
| Total Liabilities & Equity | 3,055 | 2,307 | 2,240 | 2,048 | 2,037 | Upgrade
|
| Total Debt | 1,015 | 854.99 | 902.1 | 815.33 | 855.02 | Upgrade
|
| Net Cash (Debt) | -592.81 | -633.02 | -645.42 | -580.7 | -667.27 | Upgrade
|
| Net Cash Per Share | -0.44 | -0.48 | -0.48 | -0.44 | -0.50 | Upgrade
|
| Filing Date Shares Outstanding | 1,333 | 1,333 | 1,333 | 1,333 | 1,333 | Upgrade
|
| Total Common Shares Outstanding | 1,333 | 1,333 | 1,333 | 1,333 | 1,333 | Upgrade
|
| Working Capital | 770.87 | -142.08 | 580.87 | 558.59 | 475.15 | Upgrade
|
| Book Value Per Share | 1.30 | 0.97 | 0.91 | 0.87 | 0.82 | Upgrade
|
| Tangible Book Value | 1,235 | 831.93 | 777.3 | 777.65 | 769.12 | Upgrade
|
| Tangible Book Value Per Share | 0.93 | 0.62 | 0.58 | 0.58 | 0.58 | Upgrade
|
| Land | 1,200 | 765 | 765.7 | 792.7 | 792.7 | Upgrade
|
| Machinery | 153.54 | 118.05 | 115.29 | 118.53 | 100.42 | Upgrade
|
| Leasehold Improvements | 111.95 | 107.92 | 103.79 | 146.79 | 138.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.